These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11668488)

  • 41. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version.
    Montazeri A; Harirchi I; Vahdani M; Khaleghi F; Jarvandi S; Ebrahimi M; Haji-Mahmoodi M
    Support Care Cancer; 1999 Nov; 7(6):400-6. PubMed ID: 10541982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire.
    Pistevou-Gombaki K; Eleftheriadis N; Plataniotis GA; Sofroniadis I; Kouloulias VE
    Palliat Med; 2003 Apr; 17(3):257-62. PubMed ID: 12725479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life.
    Mystakidou K; Tsilika E; Parpa E; Katsouda E; Galanos A; Vlahos L
    Qual Life Res; 2005 Oct; 14(8):1825-33. PubMed ID: 16155770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
    Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
    Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
    Hesari AE; Lari MA; Shandiz FH
    Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation study of the EORTC information questionnaire (EORTC QLQ-INFO25) in Iranian cancer patients.
    Asadi-Lari M; Ahmadi Pishkuhi M; Almasi-Hashiani A; Safiri S; Sepidarkish M
    Support Care Cancer; 2015 Jul; 23(7):1875-82. PubMed ID: 25475735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer.
    Stockler MR; Osoba D; Goodwin P; Corey P; Tannock IF
    J Clin Epidemiol; 1998 Feb; 51(2):137-45. PubMed ID: 9474074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 15-Palliative Care.
    Shin DW; Choi JE; Miyashita M; Choi JY; Kang J; Baik YJ; Mo HN; Park J; Kim HJ; Park EC
    J Pain Symptom Manage; 2011 Feb; 41(2):478-84. PubMed ID: 21145697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychometric properties of the EORTC Quality of Life Questionnaire in inpatient cancer rehabilitation in Germany.
    Dirmaier J; Zaun S; Koch U; Harfst T; Schulz H
    Palliat Support Care; 2004 Jun; 2(2):115-24. PubMed ID: 16594241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-efficacy for coping: utility of the Cancer behavior inventory (Italian) for use in palliative care.
    Serpentini S; Del Bianco P; Chirico A; Merluzzi TV; Martino R; Lucidi F; De Salvo GL; Trentin L; Capovilla E
    BMC Palliat Care; 2019 Apr; 18(1):34. PubMed ID: 30953485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.
    Chie WC; Yang CH; Hsu C; Yang PC
    Qual Life Res; 2004 Feb; 13(1):257-62. PubMed ID: 15058806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
    Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
    Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
    Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
    Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.